Portola Pharmaceuticals Inc. buy tamam
Start price
03.01.19
/
50%
€17.16
Target price
06.07.20
€21.49
Performance (%)
-6.71%
End price
06.07.20
-
Summary
This prediction ended on 06.07.20 with a price of -. With a performance of -6.71%, the BUY prediction by tamam finished with a loss. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by tamam for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 03.01.2019 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 35.83$ zu.
Kursziel geändert auf 21,492
Stopped prediction by tamam for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.54
02.01.18
02.01.18
€63.14
02.01.19
02.01.19
-60.47%
02.01.19
02.01.19
